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Abstract 
We aimed to develop cut-points for directly measured peak oxygen uptake (V̇O2peak) to identify 
boys and girls at increased cardiometabolic risk using different scaling methods to control for 
body size and composition. Altogether 352 children (186 boys, 166 girls) aged 9–11 years were 
included in the analyses. We measured V̇O2peak directly during a maximal cycle ergometer 
exercise test and lean body mass (LM) by bioelectrical impedance. We computed a sex- and 
age-specific cardiometabolic risk score (CRS) by summing important cardiometabolic risk 
factors and defined increased cardiometabolic risk as >1 standard deviation above the mean of 
CRS. Receiver operating characteristics curves were used to detect V̇O2peak cut-points for 
increased cardiometabolic risk. Boys with V̇O2peak <45.8 mL·kg body mass (BM)-1·min-1 (95% 
confidence interval [CI] = 45.1 to 54.6, area under the curve [AUC] = 0.86, p<0.001) and <63.2 
mL·kg LM-1·min-1 (95% CI = 52.4 to 67.5, AUC = 0.65, p=0.006) had an increased CRS. Girls 
with V̇O2peak <44.1 mL·kg BM-1·min-1 (95% CI = 44.0 to 58.6, AUC = 0.67, p=0.013) had an 
increased CRS. V̇O2peak scaled by BM-0.49 and LM-0.77 derived from log-linear allometric 
modelling poorly predicted increased cardiometabolic risk in boys and girls. In conclusion, 
directly measured V̇O2peak <45.8 mL·kg BM-1·min-1 among boys and <44.1 mL·kg BM-1·min-
1 among girls were cut-points to identify those at increased cardiometabolic risk. Appropriately 
controlling for body size and composition reduced the ability of cardiorespiratory fitness to 
identify children at increased cardiometabolic risk. Keywords: Aerobic fitness, Metabolic 
health, Adiposity, Children, Allometric scaling, Maximal exercise 
 
 
 
 
1 INTRODUCTION 1 
 2 
An increased cardiometabolic risk in childhood has been associated with an elevated risk of 3 
metabolic syndrome and type 2 diabetes, increased arterial stiffness, endothelial dysfunction, 4 
and preclinical carotid atherosclerosis in adulthood.1–4 Therefore, the early identification of 5 
children with increased cardiometabolic risk is important to prevent cardiometabolic diseases 6 
in adulthood. Decreased cardiorespiratory fitness (CRF), independent of the levels of physical 7 
activity, has been considered a strong determinant of increased cardiometabolic risk in children 8 
and adolescents.5–9 However, only a few studies have investigated cut-points for CRF to 9 
identify children at increased cardiometabolic risk.10–17  10 
Previous studies have suggested that peak oxygen uptake (V̇O2peak) lower than 44.0 mL·kg 11 
body mass (BM)-1·min-1 in boys and lower than 39.5 mL·kg BM-1·min-1 in girls are indicative 12 
of increased cardiometabolic risk.10–12,17 Furthermore, the most recent FITNESSGRAM 13 
guidelines suggest that boys with V̇O2peak 37.3 to 41.2 mL·kg BM-1·min-1 and girls with V̇O2peak 14 
35.3 to 37.3 mL·kg BM-1·min-1 depending on their age have an increased risk of metabolic 15 
syndrome.13,18 However, these studies have measured workload or heart rate during a 16 
submaximal treadmill or cycle ergometer exercise test, a stage reached during a 20-meter 17 
shuttle run test, or other types of exercise tests and converted these measures of performance 18 
into an estimate of V̇O2peak10–13,15,17 instead of measuring V̇O2peak directly during a maximal 19 
exercise test continued until exhaustion. Estimated V̇O2peak obtained from these types of 20 
exercise tests is problematic in that it has, at best, 50% agreement with directly measured 21 
V̇O2peak.19 Furthermore, V̇O2peak thresholds obtained from these studies are based on V̇O2peak 22 
divided by BM that is confounded by body fat content and may invalidate V̇O2peak as a measure 23 
of CRF in children with increased body mass and particularly adiposity.10–13,17,20–22 24 
Allometric scaling of V̇O2peak by measures of body size and composition using log-linear 25 
regression can partly overcome the problems related to scaling of V̇O2peak by BM using the 26 
ratio standard method.23 Nonetheless, allometrically scaled V̇O2peak for lean body mass (LM) 27 
is regarded superior to allometrically scaled V̇O2peak for BM in order to account for variance in 28 
body fat content in the expression of V̇O2peak among children and adolescents.24–29 Thus, 29 
allometrically scaled V̇O2peak by LM has been recommended as the best approach in expressing 30 
V̇O2peak among children and adolescents.29 However, there are few studies on the associations 31 
of CRF with cardiometabolic risk having appropriately controlled for body size and 32 
composition using the allometric methods or the ratio standard methods.22 Using these 33 
approaches has attenuated the associations of CRF with cardiometabolic risk,22 suggesting that 34 
CRF expressed in these manners has inferior predictive power compared to CRF scaled by BM. 35 
The aim of this study was to provide cut-points for V̇O2peak measured directly during a maximal 36 
cycle ergometer exercise test among boys and girls to identify those who are at increased 37 
cardiometabolic risk. We used different methods for scaling V̇O2peak to control for body size 38 
and composition. 39 
2 METHODS 40 
 41 
2.1 Study design and study population 42 
 43 
The Physical Activity and Nutrition in Children (PANIC) Study is an ongoing physical activity 44 
and dietary intervention study (ClinicalTrials.gov NCT01803776) in a population sample of 45 
primary school children living in the city of Kuopio, Finland. Altogether 736 children 6–9 46 
years of age who had been registered for the first grade in one of the 16 public schools of the 47 
city of Kuopio were invited for baseline examinations in 2007–2009.  48 
Altogether 512 children (248 girls, 264 boys), who accounted for 70% of those invited, 49 
participated in the baseline examinations in 2007–2009. The participants did not differ in sex 50 
distribution, age, or body mass index standard deviation score (BMI-SDS) from all children 51 
who started the first grade in the city of Kuopio in 2007–2009 based on data from the standard 52 
school health examinations performed for all Finnish children before the first grade.30 The 53 
present analyses are based on the 2-year follow-up data. We had complete data on variables 54 
needed in the analyses for 352 children (186 boys, 166 girls) 9–11 years of age. Of these 55 
children, 99.1% are Caucasians.  56 
The PANIC Study protocol was approved by the Research Ethics Committee of the Hospital 57 
District of Northern Savo. A written informed consent was acquired from the parent or 58 
caregiver of each child and every child provided assent to participation. 59 
2.2 Assessment of cardiorespiratory fitness  60 
 61 
We assessed CRF by a maximal exercise test using the Ergoselect 200 K® electromagnetic 62 
cycle ergometer coupled with a paediatric saddle module (Ergoline, Bitz, Germany), as 63 
explained in detail earlier.30 The children and their parents and caregivers were informed about 64 
the exercise test in the invitation letter. A research nurse and a research physician gave the 65 
children instructions on how to perform the exercise test. The children were familiarised with 66 
the exercise test protocol two years earlier during baseline examination. They were also 67 
allowed to practice cycling with the ergometer and using the paediatric mask 10 minutes before 68 
the exercise test. The exercise test protocol, supervised by the research physician and assisted 69 
by the research nurse, included a 2.5-minute anticipatory period with the child sitting on the 70 
ergometer; a 3-minute warm-up period with a workload of five watts; a 1-minute steady-state 71 
period with a workload of 20 watts; an exercise period with an increase in the workload of one 72 
watt per six seconds until exhaustion, and a 4-minute recovery period with a workload of five 73 
watts. 74 
The children were asked to keep the cadence stable and within 70–80 revolutions per minute. 75 
The children were verbally encouraged to exercise until voluntary exhaustion. Heart rate was 76 
measured continuously throughout the exercise test using a 12-lead electrocardiogram (ECG) 77 
registered by the Cardiosoft® V6.5 Diagnostic System (GE Healthcare Medical Systems, 78 
Freiburg, Germany). The exercise test was considered maximal if the peak heart rate was at 79 
least 185 beats per minute and the respiratory exchange ratio was at least 1.0.31 However, the 80 
research physician also adjudged the exercise test maximal among 21 (6%) children with a 81 
peak heart rate of 179-184 beats per minute, because the cadence dropped below 65 revolutions 82 
per minute although the children still had the motivation to continue and the reason for 83 
terminating the test suggested a maximal effort had been provided.30 The peak workload was 84 
defined as the workload at the end of the exercise test.  85 
The respiratory gas analysis was performed during the exercise test from the beginning of the 86 
2.5-minute anticipatory period before the exercise test to the end of the 4-minute recovery 87 
period after the exercise test using the Oxycon Pro® respiratory gas analyzer (Jaeger, 88 
Hoechberg, Germany) and the Hans-Rudolph® paediatric mask (Shawnee, Kansas, USA). 89 
V̇O2peak was measured using the breath-by-breath method and was averaged over consecutive 90 
15-second periods. V̇O2peak and the respiratory exchange ratio were defined as the highest 15-91 
seconds average values recorded during the last minute of the exercise test.30 92 
2.3 Assessment of cardiometabolic risk factors 93 
 94 
Cardiometabolic risk factors were assessed in the morning for two children, first of them 95 
arriving at 08:00 and second at 09:15. The research nurse measured body height, body weight, 96 
and waist circumference using standard protocols.32 Body mass index (BMI) was calculated by 97 
dividing body weight with body height squared and BMI-SDS using national references.33 The 98 
prevalence of overweight and obesity was defined using age- and sex-specific cut-points.33 99 
Total body fat mass, body fat percentage (BF%), and LM were measured twice; the children 100 
having fasted for 12 hours, voided the bladder; and standing in light underwear, using the 101 
InBody® 720 bioelectrical impedance device (Biospace, Seoul, South Korea). We have found 102 
a good agreement between BF% and LM measured with bioelectrical impedance and those 103 
derived from dual-energy X-ray absorptiometry.34 The research nurse measured blood pressure 104 
manually from the right arm by a calibrated Heine 130 Gamma G7® aneroid 105 
sphygmomanometer (Heine Optotechnik, Herrsching, Germany). The measurement protocol 106 
included a 5-minute rest and thereafter three measurements in a sitting position at 2-minute 107 
intervals. The mean of all three values was used as the systolic and diastolic blood pressure. 108 
The research nurse took venous blood samples using a standard protocol after a 12-hour fast 109 
and the children having seated for 10 minutes. The assessment of serum insulin and plasma 110 
glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein 111 
(LDL) cholesterol, and triglycerides, have been explained in detail earlier.35  112 
2.4 Assessment of puberty 113 
The research physician assessed pubertal status using a 5-stage scale described by Tanner.36,37 114 
Boys were defined having entered clinical puberty if their testicular volume assessed by an 115 
orchidometer was ≥4 mL (Tanner stage ≥2).37 Girls were defined having entered clinical 116 
puberty if their breast development had started (Tanner stage ≥2).36  117 
2.5 Calculation of cardiometabolic risk score 118 
 119 
We calculated a continuous cardiometabolic risk score using population-specific and age- and 120 
sex-standardized Z-scores for waist circumference, insulin, glucose, HDL cholesterol, 121 
triglycerides, and the average of systolic and diastolic blood pressure by a formula: waist 122 
circumference + insulin + glucose - HDL cholesterol + triglycerides + the average of systolic 123 
and diastolic blood pressure.38 We defined elevated cardiometabolic risk as ≥1 standard 124 
deviation above the mean of the cardiometabolic risk score in the present study population. The 125 
rationale for using this approach is the existing evidence on the ability of a continuous 126 
cardiometabolic risk score in children to predict cardiometabolic diseases in adulthood.39 The 127 
clustering of risk factors may also provide a more sensitive and clinically more relevant 128 
evaluation of increased cardiometabolic risk than using individual risk factors,40,41 and may 129 
compensate for day-to-day fluctuations observed in the levels of individual risk factors.42 130 
2.6 Allometric scaling of peak oxygen uptake 131 
 132 
Allometric scaling of V̇O2peak was performed by the log-linear regression model43 with sex and 133 
BM or LM as independent variables and V̇O2peak as a dependent variable. The scaling exponent 134 
(b) was identified in the allometric equation V̇O2peak = Y/Xb, where X is the anthropometric 135 
scaling variable (BM or LM). V̇O2peak and X were log transformed and least squares regression 136 
with the equation ln (V̇O2peak) = lnY / b ln(X) was used to obtain the scaling exponent b. We 137 
found that the scaling exponent b for BM was 0.49 (95% confidence interval [CI] = 0.43 to 138 
0.55) and that for LM was 0.77 (95% CI = 0.70 to 0.85). To test if the slopes of the association 139 
of V̇O2peak with BM and LM were similar in boys and girls, we added the interaction term to 140 
the model. The interactions of sex with BM (p = 0.362) and LM (p = 0.932) were not 141 
statistically significant. These allometric models were able to remove the associations of 142 
V̇O2peak with BM (r = -0.072, p = 0.328) and LM (r = 0.022, p = 0.939), indicating their validity 143 
in scaling CRF. 144 
2.7 Statistical methods 145 
 146 
Student’s t-test, Mann–Whitney U test, and Chi-square test were used to compare basic 147 
characteristics between boys and girls. The associations of measures of CRF with the 148 
cardiometabolic risk score were studied using linear regression analyses. The associations were 149 
adjusted for age and study group and additionally for puberty. Receiver operating 150 
characteristics (ROC) curves were used to investigate V̇O2peak cut-points associated with 151 
increased cardiometabolic risk. We decided not to provide cut-points for allometrically scaled 152 
V̇O2peak because they would depend on the scaling exponent b that is specific to our study 153 
population. Moreover, a recent review has highlighted that no general scaling exponent b is 154 
available.29 The area under the curve (AUC) was used as a measure of the effectiveness of the 155 
predictor variable to identify correctly children having a cardiometabolic risk score ≥ +1 SD 156 
(sensitivity) and to identify correctly children having a cardiometabolic risk score <1 SD 157 
(specificity). An AUC of 1.0 represents the ability to identify perfectly children having a 158 
cardiometabolic risk score ≥ +1 SD from other children, whereas an AUC of 0.5 indicates no 159 
greater predictive ability than chance. We also compared the cardiometabolic risk score in the 160 
categories of V̇O2peak scaled by BM and LM among boys and girls combined using analysis of 161 
covariance with Sidak correction adjusted for age and the study group. In these analyses, we 162 
used sex-specific categories of V̇O2peak scaled by BM and LM according to the distributions of 163 
these variables [very low (<2.5 %), low (2.5–15.9 %), medium (16–83.9 %), high (84–97.5 %), 164 
very high (>97.5 %)] as defined in our earlier study in the same paediatric population.30 We 165 
combined children in the two highest categories because of the small number of children in the 166 
highest category to increase statistical power in these analyses. Student’s t-tests, Mann–167 
Whitney U tests, Chi-square tests, and linear regression analyses were conducted using the 168 
SPSS statistics software, version 23.0 (IBM Corp, Armonk, NY, USA). ROC curve analyses 169 
were performed using the MedCalc® statistical software, version 16.1 (MedCalc® Software 170 
bvba, Ostend, Belgium). Our power calculation provided a sample size of 352 children. In this 171 
calculation, we determined the effect size that corresponds to the power of 0.8 at 0.05 alpha to 172 
test differences in the associations of CRF within sex-specific categories and cardiometabolic 173 
risk. Cohen’s d effect size for F-test (d = 0.177) was derived using the G*Power statistical 174 
software, version 3.1.9.2. Cohen’s d effect size for F-test is interpreted as small for d = 0.1, 175 
medium for d = 0.25, and large for d = 0.4. 176 
3 RESULTS 177 
 178 
3.1 Characteristics of children 179 
 180 
Boys had more LM, less fat mass, a lower BF%, a higher waist circumference, lower insulin, 181 
higher glucose, higher HDL cholesterol, and higher V̇O2peak scaled by BM and LM compared 182 
to girls (Table 1). 183 
3.2 Associations of peak oxygen uptake with cardiometabolic risk  184 
 185 
Absolute V̇O2peak expressed in mL·min-1 was directly associated with cardiometabolic risk in 186 
boys and girls adjusted for age and the study group (Table 2). V̇O2peak scaled by BM and LM 187 
were inversely related to cardiometabolic risk in boys and girls after these adjustments. 188 
Allometrically scaled V̇O2peak expressed in mL·kg BM-0.49·min-1 and mL·kg LM-0.77·min-1 were 189 
also inversely associated with cardiometabolic risk in boys. Moreover, allometrically scaled 190 
V̇O2peak expressed in mL·kg LM-0.77·min-1, but not allometrically scaled V̇O2peak expressed in 191 
mL·kg BM-0.49·min-1, was associated with cardiometabolic risk among girls. These 192 
relationships in boys and girls were unaltered after additional adjustment for puberty (data not 193 
shown). 194 
3.3 Peak oxygen uptake in identifying children with increased cardiometabolic risk  195 
 196 
In boys, V̇O2peak less than 45.8 mL·kg BM-1·min-1 and V̇O2peak less than 63.2 mL·kg LM-1·min-197 
1 were associated with increased cardiometabolic risk. Allometrically scaled V̇O2peak expressed 198 
in mL·kg BM-0.49·min-1 and in mL·kg LM-0.77·min-1 also differentiated boys with increased 199 
cardiometabolic risk (Table 3).  200 
In girls, V̇O2peak less than 44.1 mL·kg BM-1·min-1 was associated with increased 201 
cardiometabolic risk. However, neither V̇O2peak scaled by LM nor allometrically scaled V̇O2peak 202 
for BM or LM was able to differentiate girls with increased cardiometabolic risk. 203 
3.4 Cardiometabolic risk among children in categories of peak oxygen uptake 204 
 205 
Cardiometabolic risk decreased in a dose-dependent manner with increasing categories of 206 
V̇O2peak expressed in mL·kg BM-1·min-1 among children (p<0.001 for linear trend) (Figure 1). 207 
Moreover, children in the highest category of V̇O2peak expressed in mL·kg LM-1·min-1 also had 208 
a lower cardiometabolic risk than children in other categories of V̇O2peak (Figure 1).  209 
DISCUSSION 210 
We found a strong inverse association between directly measured V̇O2peak scaled by BM and 211 
cardiometabolic risk among boys and girls. V̇O2peak less than 45.8 mL·kg BM-1·min-1 in boys 212 
and 44.1 mL·kg BM-1·min-1 in girls was associated with increased cardiometabolic risk with 213 
moderate sensitivity and specificity. However, the inverse associations of V̇O2peak scaled by 214 
LM or V̇O2peak scaled by BM-0.49 and LM-0.77 derived from log-linear allometric modelling with 215 
cardiometabolic risk were markedly weaker. V̇O2peak less than 63.2 mL·kg LM-1·min-1 was 216 
linked to increased cardiometabolic risk in boys, although sensitivity was poor. Furthermore, 217 
V̇O2peak scaled by allometric methods was able to differentiate boys at increased 218 
cardiometabolic risk with adequate sensitivity but poor specificity. Neither V̇O2peak scaled by 219 
LM nor allometrically scaled V̇O2peak for BM or LM was able to differentiate girls with 220 
increased cardiometabolic risk.  221 
Our results are in agreement with previous findings that CRF measured in exercise test 222 
laboratories or using field tests and scaled by BM using the ratio standard method had a strong 223 
inverse association with cardiometabolic risk in children.10–12 However, the inverse 224 
relationship between CRF scaled by BM and cardiometabolic risk is partly confounded by 225 
adiposity, because CRF divided by BM is a measure of both CRF and body fat content. We 226 
observed that using V̇O2peak scaled by LM or allometric scaling of V̇O2peak for BM or LM 227 
instead of V̇O2peak scaled by BM attenuated the magnitude of the inverse association between 228 
CRF and cardiometabolic risk by 50-75%. These results are in consonance with the observation 229 
that estimated V̇O2peak scaled by BM provided spurious associations with cardiometabolic risk 230 
among children and the view that V̇O2peak scaled allometrically or by fat free mass would be a 231 
better measure to estimate the magnitude of the association between CRF and cardiometabolic 232 
risk.22 Notwithstanding, the measures of CRF scaled by LM may also be influenced by 233 
adiposity because individuals with higher fat mass also have higher LM.44 In the present cross-234 
sectional study, adjusting for puberty had no effect on the relationships between V̇O2peak and 235 
cardiometabolic risk in boys or girls. Therefore, longitudinal studies are needed to clarify the 236 
role of CRF in cardiometabolic health during growth and maturation. It is also important to 237 
note that CRF is strongly influenced by genetic factors45 and some genetic variants have been 238 
reported to modify the relationship between CRF and cardiometabolic risk factors, such as 239 
adiposity, insulin resistance, and elevated blood pressure.45 In our study, genetics may play a 240 
role in the inverse association between CRF controlled for body fat and cardiometabolic risk.46 241 
The cut-point for V̇O2peak of 45.8 mL·kg BM-1·min-1 to identify boys aged 9-11 years at 242 
increased cardiometabolic risk in our study corresponds well with the previously reported cut-243 
point for V̇O2peak of 43.6 mL·kg BM-1·min-1 among boys aged 8-11 years.10 However, the cut-244 
point for V̇O2peak of 44.1 mL·kg BM-1·min-1 to identify girls aged 9-11 years at increased 245 
cardiometabolic risk in our study was notably higher than the cut-point for V̇O2peak of 37.0 246 
mL·kg BM-1·min-1 observed among girls aged 9-10 years in a previous study.15 The reason for 247 
a higher threshold for V̇O2peak among girls in our study than in the earlier study may be that 248 
Finnish girls aged 9-11 years are more fit than girls of the same age in other paediatric 249 
populations. However, Welk and co-workers13 found that the cut-point for estimated V̇O2peak 250 
to identify children aged 10-11 years at increased cardiometabolic risk was 40.2 mL·kg BM-251 
1·min-1 in both sexes. The diversity in cut-points may also be due to the different age ranges of 252 
children because most of the earlier studies have reported pooled data of various age 253 
groups.10,11,14 There is some evidence that the cut-point for V̇O2peak decreases with increasing 254 
age in girls, whereas it remains relatively stable in boys.31 One explanation for this sex 255 
difference may be that body fat content increases more in girls than in boys during maturation 256 
that introduces more confounding by adiposity in the measurement of CRF in girls.47 Another 257 
reason for the array of cut-points for V̇O2peak scaled by BM may be that the prevalence of 258 
overweight has varied among the study populations.13,23 Moreover, different assessments of 259 
CRF and cardiometabolic risk factors and different definitions of increased risk may explain 260 
the incongruence in CRF cut-points among these studies.10–13,17 In consonance with earlier 261 
studies,10,12,15 the prevalence of increased cardiometabolic risk defined by ≥ +1 SD of the 262 
cardiometabolic risk score in our study was 25% among boys and 34% in girls. 263 
We found moderate sensitivity and specificity of the measures of CRF in predicting increased 264 
cardiometabolic risk which corresponds to those of previous studies.10–12,15 Sensitivity for 265 
V̇O2peak scaled by BM was 75% in boys and 69% in girls. This sex difference may be due to a 266 
stronger inverse association between CRF and cardiometabolic risk in boys than in girls.13 267 
Nonetheless, the false positive rate would be too high for screening children with increased 268 
cardiometabolic risk using V̇O2peak scaled by BM. There is a trade-off between false-positive 269 
and false-negative rates. Classification accuracy may lead to the problem of fictitious 270 
interpretation when applying cut-points with a high false positive rate than those with a high 271 
false negative rate. Improving CRF may decrease cardiometabolic risk, however, a large 272 
number of false positive cases would result in failure to correctly identify children at increased 273 
risk, in contrast to recommending increased physical activity to improve CRF in false negative 274 
cases.10 It is important that children are not subject of the social stigma associated with being 275 
erroneously classified as being at increased cardiometabolic risk. In addition, it is better to err 276 
on the side of caution so that children who truly are at increased risk are not deprived of health 277 
care.10 278 
Loftin and co-workers suggested that V̇O2peak should be allometrically scaled for LM due to 279 
the involvement of skeletal muscle in locomotion.29 We found that V̇O2peak scaled by LM had 280 
worse ability to differentiate boys with increased cardiometabolic risk than V̇O2peak scaled by 281 
BM. Neither V̇O2peak scaled allometrically nor V̇O2peak scaled by LM could differentiate girls 282 
with increased cardiometabolic risk. Appropriately scaled CRF resulted in a poor prediction of 283 
cardiometabolic risk; whereas, CRF scaled by BM using the ratio standard method, was a better 284 
predictor of cardiometabolic risk. The reason for this is that CRF scaled by BM combines the 285 
information from these two measures such that both decreased CRF and increased weight 286 
and/or body fat content are associated with increased cardiometabolic risk. Proposing age-287 
specific cut-points for CRF scaled by BM using the ratio standard method offers clear 288 
diagnostic utility in identifying children at increased cardiometabolic risk, which tracks well 289 
from childhood into adulthood.39 There was a linear decrease in cardiometabolic risk with 290 
increasing categories of V̇O2peak scaled by BM. Similarly, children in the highest category of 291 
V̇O2peak scaled by LM had reduced cardiometabolic risk compared to other children. However, 292 
the differences in cardiometabolic risk across the categories of V̇O2peak scaled by LM were 293 
markedly smaller than those of V̇O2peak scaled by BM. 294 
The strengths of this study include a large population sample of children 9-11 years of age, the 295 
direct assessment of V̇O2peak, and the use of V̇O2peak scaled allometrically for BM and LM. Our 296 
study provides a robust threshold for V̇O2peak scaled by BM in these children aged 9-11 years, 297 
however, we cannot extrapolate our findings to other age groups. Our study participants were 298 
Caucasian children, so the cut-points may not be generalised to children of different ethnic 299 
groups. A limitation of the study is its cross-sectional design that does not allow us to arrive at 300 
a conclusion regarding the causality of the association between CRF and cardiometabolic risk. 301 
Therefore, longitudinal studies are warranted in order to investigate whether a decrease in 302 
adiposity-independent measures of CRF is associated with an increase in cardiometabolic risk 303 
over time among children and adolescents. In addition, it would be important to provide 304 
evidence for the effects of growth and maturation on the cut-points for CRF using different 305 
methods to scale CRF for body size and composition. 306 
In conclusion, we found that directly measured V̇O2peak less than 45.8 mL·kg BM-1·min-1 in 307 
boys 9-11 years of age and less than 44.1 mL·kg BM-1·min-1 in girls 9-11 years of age was 308 
associated with increased cardiometabolic risk with moderate sensitivity and specificity. The 309 
association of CRF scaled by BM with cardiometabolic risk was markedly weaker than that of 310 
CRF scaled by LM because scaling by LM reduced the dependence of the measure of CRF on 311 
adiposity. Appropriately controlling for body size and composition reduced the ability of CRF 312 
to identify boys and girls at increased cardiometabolic risk. 313 
5 PERSPECTIVES 314 
 315 
Cardiometabolic risk tracks from childhood into adulthood and the early identification of 316 
individuals at increased risk is essential in developing public health actions targeted at 317 
preventing cardiometabolic diseases. Our results showed that CRF scaled by BM, which is 318 
partly confounded by adiposity, had a strong inverse association with cardiometabolic risk 319 
among children. Appropriately controlling for body size and composition markedly attenuated 320 
the predictive ability of CRF. The strong inverse association between CRF scaled by BM and 321 
cardiometabolic risk suggests that CRF scaled by BM can be used in screening children at 322 
increased cardiometabolic risk. However, children may be erroneously classified as being at 323 
increased risk, which may subject them to social stigma. Hence, there should be cautious 324 
interpretation and utilization of CRF thresholds so that children who truly are at increased 325 
cardiometabolic risk are not deprived of appropriate intervention. 326 
A markedly weakened relationship between CRF and increased cardiometabolic risk when 327 
adiposity was appropriately controlled for raises the question of whether there is an aetiological 328 
link between CRF and cardiometabolic health in children. Hence, longitudinal research is 329 
needed to establish whether decreased CRF, using appropriate scaling methods to control for 330 
body size and composition, increases cardiometabolic risk among children. 331 
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Figure 1: Differences in cardiometabolic risk score according to sex-specific V̇O2peak 509 
distribution using analysis of covariance (ANCOVA) with Sidak correction, adjusted for age 510 
and study group 511 
 512 
 513 
 514 
Table 1. Characteristics of 352 children  515 
 Boys 
(n=186) 
Girls 
(n=166) 
P for 
difference 
Age (y) 9.8 (0.5) 9.8 (0.4) 0.696 
Body height (cm) 141.5 (6.0) 140.4 (6.6) 0.127 
Body weight (kg) 34.3 (9.7)* 33.1 (9.6)* 0.248 
Clinical Puberty (%)† 15.1 37.7 <0.001 
Overweight and obesity (%) 19.9 18.7 0.773 
Waist circumference (cm) 61.7 (9.1)* 59.4 (9.5)* 0.012 
Body fat mass (kg) 5.5 (5.6)* 6.1 (5.8)* 0.009 
Body fat percentage (%) 15.9 (11.1)* 18.3 (11.0)* <0.001 
Lean body mass (kg) 27.0 (3.6) 25.3 (3.5) <0.001 
Serum insulin (pmol/L) 4.9 (3.9)* 6.1 (4.4)* <0.001 
Plasma glucose (mmol/L) 5.0 (0.3)* 4.9 (0.4)* <0.001 
Plasma HDL cholesterol (mmol/L) 1.7 (0.3) 1.6 (0.3) 0.040 
Plasma triglycerides (mmol/L) 0.6 (0.3)* 0.5 (0.3)* 0.916 
Systolic Blood Pressure (mm Hg) 100.0 (8.0) 101.0 (7.0) 0.795 
Diastolic Blood Pressure (mm Hg) 61.2 (7.5) 61.4 (7.7) 0.830 
Peak heart rate (beats/min) 198.8 (8.7) 200.1 (8.6) 0.167 
Peak Respiratory exchange ratio 1.1 (0.1) 1.1 (0.1) <0.001 
V̇O2peak (mL·kg BM-1·min-1) 52.0 (7.0) 46.3 (6.9) <0.001 
V̇O2peak (mL·kg LM-1·min-1) 66.7 (6.5) 61.9 (6.5) <0.001 
V̇O2peak (mL·kg BM-0.49·min-1) 314.0 (37.0) 277.0 (33.0) <0.001 
V̇O2peak (mL·kg LM-0.77·min-1) 224.0 (21.0) 207.0 (21.0) <0.001 
Cardiometabolic risk score 0.18 (3.6) 0.13 (3.5) 0.878 
The values are means (standard deviations) from the Student’s t-test for normally distributed 516 
variables, medians (interquartile ranges) from the Mann–Whitney U test for variables with 517 
skewed distributions*, or percentages from the Chi-square test for categorical variables.  518 
BM, body mass; HDL, high density lipoprotein; LM, lean body mass; V̇O2peak; peak oxygen 519 
uptake.  520 
†Boys were defined having entered clinical puberty if their testicular volume assessed by an 521 
orchidometer was ≥4 mL (Tanner stage ≥2).37 Girls were defined having entered clinical 522 
puberty if their breast development had started (Tanner stage ≥2).36 523 
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 529 
 530 
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 532 
 533 
 534 
Table 2. Associations of peak oxygen uptake with cardiometabolic risk score in boys and 
girls 
         Boys (n=186)       Girls (n=166) 
 β p β p 
V̇O2peak (mL·min-1) 0.229 0.002 0.356 <0.001 
V̇O2peak (mL·kg BM-1·min-1) -0.577 <0.001 -0.484 <0.001 
V̇O2peak (mL·kg LM-1·min-1) -0.252 0.001 -0.245 0.001 
V̇O2peak (mL·kg BM-0.49·min-1) -0.261 <0.001 -0.123 0.127 
V̇O2peak (mL·kg LM-0.77·min-1) -0.185 0.012 -0.166 0.036 
The values are standardised regression coefficients and p-values from linear regression models 535 
adjusted for age and the study group. 536 
 537 
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 543 
 544 
 545 
Table 3. Receiver operating characteristics curve analyses to predict increased cardiometabolic risk in boys and girls. 546 
                                           Boys (n=186)                                                       Girls (n=166) 
 Cut-points Sensitivity Specificity AUC 95% CI p-value Cut-points Sensitivity Specificity AUC 95% CI p-value 
V̇O2peak (mL·kg BM-1·min-1) < 45.8 75.0 85.4 0.86 0.80 - 0.90 < 0.001 44.1 69.6 69.2 0.69 0.59 - 0.74 0.013 
V̇O2peak (mL·kg LM-1·min-1) < 63.2 50.0 76.6 0.65 0.58 - 0.72 0.006 *   0.57 0.49 - 0.65 0.332 
V̇O2peak (mL·kg BM-0.49·min-1) ** 78.6 55.0 0.66 0.59 - 0.73 0.027 *   0.50 0.42 - 0.58 0.977 
V̇O2peak (mL·kg LM-0.77·min-1) ** 75.0 46.8 0.61 0.54 - 0.68 0.047 *   0.53 0.45 - 0.61 0.633 
AUC, area under the curve; CI, confidence interval; 547 
*Scaled V̇O2peak could not differentiate girls with cardiometabolic risk. 548 
**Cut-points were not provided because they would depend on the scaling exponent that are specific to our study population. 549 
